The need to intensify oral diuretic therapy in patients who have heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) is significantly decreased with finerenone (Kerendia; ...

(HealthDay News) — Ambulatory, high-dose intravenous diuretic therapy seems to be cost saving for decompensated heart failure, according to a study published in The American Journal of Cardiology. Leo ...

Loop diuretics are an essential component of therapy for patients with acute decompensated heart failure, but there are few prospective data to guide their use. In a prospective, double-blind, ...

Hypervolemia leads to disease progression and mortality in patients with heart failure. Intravenous diuretic therapy is the current standard of care for hypervolemic heart failure, but loop diuretics ...